There is very little data about this effect on humans, but the risk cannot be excluded
Choosing a GLP-1 for weight loss ultimately comes down to matching that mechanism, and its side-effect profile, to your health history
Understanding whats genuinely happening at each stage, from baseline through 48 weeks, gives a far more complete picture than any single after photo ever could
Also, a peer-reviewed study published by earlier this year by the research journal Obesity indicates that only 40% of obese patients taking semaglutide-based GLP-1 products were persistent at one year
Data Sharing Statement All the data used for this publication are presented in the main article
Without this stabilization, the structure becomes fragile